Navigation Links
Cellectis' Meganuclease Technology Used to Efficiently Prevent Viral Infection
Date:1/19/2011

PARIS, Jan. 19, 2011 /PRNewswire/ -- Cellectis (Alternext: ALCLS), announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1). The research has just been published online by Molecular Therapy(1) (Mol. Ther. 2011, Jan 11. Epublication ahead of print).  These are the first proof-of-concept data showing that meganucleases can prevent viral infection.

In this article, scientists used HSV-1 specific meganucleases engineered by Cellectis to successfully prevent the infection of human cultured cells by HSV-1. Subsequent analysis of the treated cells using deep sequencing techniques showed that inhibition of HSV-1 infection by the anti-HSV-1 meganucleases was associated with cleavage of viral DNA (or virus clipping). When the virus is clipped at a well-chosen and specific location, this prevents its normal activity as well as its ability to replicate and spread.

"Virus clipping using meganucleases is a new therapeutic approach to tackle persistent viral infection which could have broad applications in medicine," said Pr. Jose Alain Sahel, Director of Institut de la Vision. "We are particularly interested in the potential of meganucleases in the prevention of recurrent infection during corneal transplantation and look forward to continuing our studies in this area."

"The results published in Molecular Therapy are very exciting since they open new fields of research for fighting HSV recurrent infections, a major cause of both acquired and severe loss of vision," added Dr. Marc Labetoulle, M.D., Ph.D. of CNRS.

About HSV-1 infection

HSV-1 infection is highly prevalent globally, with an estimated 70-90% of the adult population carrying the virus. The majority of seropositive individuals are unaware th
'/>"/>

SOURCE Cellectis therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
2. Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
4. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
5. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
6. Cellectis Unveils Its New Corporate Website
7. Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store
8. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
9. Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
10. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
11. Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... neutral. That is, most of the atoms in ... electrons in the outer parts of atoms equals the ... As one or more electrons are plucked away from ... positive pull from the nucleus. This enhanced pull, ... those electrons are less vulnerable to the distractions of ...
(Date:7/18/2014)... July 18, 2014 Global biotechnology ... US offices in Cambridge, MA, announces the launch ... and Software product that leverages the power of ... Illumina® MiSeq sequencing platform. The assay and software ... Hospital of Philadelphia (CHOP) and will include a ...
(Date:7/18/2014)... 18, 2014 The International Wheat Genome Sequencing ... a draft sequence of the bread wheat genome. The ... and evolution of the large, complex genome of the ... genetic blueprint is an invaluable resource to plant science ... at their disposal a set of tools enabling them ...
(Date:7/17/2014)... 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... development and commercialization of products for the treatment of ... results for the second quarter of 2014 on Thursday, ... The Company will host a conference call at ... which Vanda management will discuss the second quarter 2014 ...
Breaking Biology Technology:Highly charged ions 2Highly charged ions 3Highly charged ions 4Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2
... Webcast and Conference Call Scheduled for Tuesday, May 13th at ... Therapeutics, Inc.,(Nasdaq: IMRX ) today announced that the Company ... 13, 2008, at 5:00 p.m. ET to discuss,first quarter 2008 ... ImaRx,s corporate website at, http://www.imarx.com and will be archived ...
... DIEGO, May 7 Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ... ended,March 31, 2008., Total revenues in the first ... in the first quarter of 2007, and included $2.0 ... Ltd,and $0.6 million in patent reimbursements from Arena,s collaborations ...
... augment Quintiles Consulting offerings, RESEARCH TRIANGLE ... today announced that it has signed an ... and market research,consulting firm located in Boston ... The acquisition of Eidetics will strengthen ...
Cached Biology Technology:Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 8Quintiles Signs Agreement to Acquire Eidetics 2
(Date:7/21/2014)... In traditional apple orchards, effective management practices ... to manage competitive vegetation under the trees, ... These factors are further complicated in organic ... and producers need to meet the stringent ... of the National Organic Program. University of ...
(Date:7/21/2014)... scientist has developed a pioneering new way using ... the effect of drugs on the heart without using ... work of Dr Helen Maddock an expert in ... Applied Biological and Exercise Sciences and could lead ... saved and the quality of their treatments improved. , ...
(Date:7/21/2014)... , July 21, 2014 Research and ... of the "Next Generation Biometric Market by ... & Analysis 2014 - 2020" report to ... Biometric technology is the verification of humans by ... palm, signature, vein, and DNA. DNA and vein ...
Breaking Biology News(10 mins):Organic apple orchards benefit from green compost applications 2New technique uses 'simulated' human heart to screen drugs 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 3
... PHILADELPHIA A study published in the December issue ... the American Association for Cancer Research, suggests that selenium, ... may aid in the prevention of high-risk bladder cancer. ... levels in 767 individuals newly diagnosed with bladder cancer ...
... Rods and cones coexist peacefully in healthy retinas. Both types ... signals when they detect light, which is the first step ... a codependent relationship between the two that can be destructive. ... them to the grave, leading to blindness. A new study ...
... examines genetic variants associated with nine metabolic traits and ... a population unselected for current disease. The traits are ... 2 diabetes, blood pressure, inflammation and lipid levels. ... about their health: these data will help researchers to ...
Cached Biology News:Selenium may prevent high risk-bladder cancer 2Progression of retinal disease linked to cell starvation 2Genes for 9 health indicators 2Genes for 9 health indicators 3
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... H2OBIT is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... ,A robotic arm rapidly transfers a basket ... temperature ramping times that are considerably faster than ...
... used gasketed gel trays. Turn the tray 90 degrees ... back and run the gel - its as simple ... tray is UV transparent. Each tray accommodates two comb ... one in the center. This allows you the option ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: